Now the Johns Hopkins University surgeon and researcher has been nominated to lead the Food and Drug Administration. The ...

Eli Lilly and Company will participate in Leerink Partners Global Healthcare Conference on March 10, 2025. Lucas Montarce, Lilly executive vice president and chief financial officer, will take part in ...

We need your help! In the next 24 hours, please ask your House representatives to use the appropriations process to ensure ...

New research shows home-measured peanut oral immunotherapy boosts peanut tolerance in allergic children, with long-term ...

Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV ...

Discover a proof-of-concept study that was conducted to explore whether dupilumab could induce desensitisation to peanut.

For children with high-threshold peanut allergy, peanut oral immunotherapy using home-measured peanut butter ingestion yields higher and sustained rates of peanut tolerance.

Palforzia is indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

Children with peanut allergy using the Viaskin peanut patch (VP250) may experience greater clinical benefit with long-term use.

SAN DIEGO -- Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than ...

Food allergy, intolerance, and sensitivity generally differ based on whether or not IgE, a protein the body can make against ...

The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...